stockrowTakeda Pharmaceutical Co. (TAK) vs Zoetis Inc. (ZTS)
- Takeda Pharmaceutical Co. TAK 21.25 +0.90%
- Zoetis Inc. ZTS 81.72 −8.39%
Takeda Pharmaceutical Co. and Zoetis Inc. are both Drug Manufacturers Specialty & Generic companies. Takeda Pharmaceutical Co. is the larger, with a market value of $67.7B against $33.9B — 2.0× the size. Zoetis Inc. trades at the lower P/E: 13.4× against 32.0×. Zoetis Inc. grew revenue faster over the last twelve months: 1.58% against 0.66%. Zoetis Inc. has the higher net margin (27.7% vs 7.12%) and the higher return on invested capital (19.6% vs 0.00%). Both pay a dividend; Zoetis Inc. yields more (2.59% vs 1.45%). Across the 23 metrics below, Zoetis Inc. leads on 17 and Takeda Pharmaceutical Co. on 6.
Valuation
Profitability
| Metric | TAK | ZTS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 65.85% | 71.67% | 53.51% |
| Operating margin | 11.61% | 37.13% | 0.00% |
| Net margin | 7.12% | 27.69% | (2.45%) |
| Free cash flow margin | 0.00% | 24.43% | 0.00% |
| Return on equity | 0.00% | 64.91% | (0.80%) |
| Return on assets | 0.00% | 17.84% | (1.67%) |
| Return on invested capital | 0.00% | 19.60% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack